SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-24-058657
Filing Date
2024-05-08
Accepted
2024-05-08 16:05:33
Documents
2
Period of Report
2024-05-06

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2413886-1_3seq1.html 3  
1 OWNERSHIP DOCUMENT tm2413886-1_3seq1.xml 3 1616
2 EXHIBIT 24 tm2413886d1_ex24.htm EX-24 10897
  Complete submission text file 0001104659-24-058657.txt   14067
Mailing Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402
Business Address 155 BOVET RD., SUITE 303 SAN MATEO CA 94402 (650) 561-8600
Sagimet Biosciences Inc. (Issuer) CIK: 0001400118 (see all company filings)

IRS No.: 205991472 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O PROVENTION BIO, INC. 55 BROAD STREET, 2ND FLOOR RED BANK NJ 07701
Business Address
Chauche Thierry (Reporting) CIK: 0001895174 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-41742 | Film No.: 24925830